Prospective Study of White Blood Cells

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Autoimmune Diseases Behavior Immune System Diseases Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Rejection, Psychology Rejection; Transplant, Liver Social Behavior

Sex eligibility

All sexes

Study type

Observational

Primary location

Quell Investigator Site 01

London, United Kingdom

Location status: Recruiting

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions.

Treatment and study plan

White blood cell and blood collection

Other

Mononucleocytes will be collected via apheresis

Primary outcomes

WBC characterisation to support the development of engineered regulatory T cells.

Time frame: 5 years

number, type and function of white blood cells in healthy controls and in patients

Study contacts

Contact information is provided by the study sponsor or research team.

Gareth Wright

CONTACT

[email protected]

+4(0)2070969012

Sponsors and collaborators

Lead sponsor

Quell Therapeutics Limited

Industry

Registry information

Official study title

Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies

Important dates

Study start: 2021
Primary completion: 2029
Study completion: 2030
First posted: Apr 8, 2021
Registry last updated: Jan 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting